Cover Image

Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia: letters to the editor

Saved in:
Bibliographic Details
Main Authors: Jaramillo Segura, Sonia (Author) , Krisam, Johannes (Author) , Le Cornet, Lucian (Author) , Kratzmann, Markus (Author) , Baumann, Lukas (Author) , Eissymont, Olga (Author) , Crysandt, Martina (Author) , Görner, Martin (Author) , Kayser, Sabine (Author) , Krause, Stefan W. (Author) , Schliemann, Christoph (Author) , Gaska, Tobias (Author) , Kaufmann, Martin (Author) , Chemnitz, Jens (Author) , Schaich, Markus (Author) , Hoellein, Alexander (Author) , Platzbecker, Uwe (Author) , Kieser, Meinhard (Author) , Müller-Tidow, Carsten (Author) , Schlenk, Richard Friedrich (Author)
Format: Article (Journal) Editorial
Language:English
Published: June, 2024
In: Haematologica
Year: 2024, Volume: 109, Issue: 6, Pages: 1973-1976
ISSN:1592-8721
DOI:10.3324/haematol.2023.284346
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2023.284346
Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/haematol.2023.284346
Get full text
Author Notes:Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet, Markus Kratzmann, Lukas Baumann, Olga Eissymont, Martina Crysandt, Martin Görner, Sabine Kayser, Stefan Krause, Christoph Schliemann, Tobias Gaska, Martin Kaufmann, Jens Chemnitz, Markus Schaich, Alexander Hoellein, Uwe Platzbecker, Meinhard Kieser, Carsten Müller-Tidow and Richard F. Schlenk
Description
Item Description:Gesehen am 18.02.2025
Physical Description:Online Resource
ISSN:1592-8721
DOI:10.3324/haematol.2023.284346

Similar Items